Ledger.Open graph →
SEC Form D · filed November 16, 2023

AILERON THERAPEUTICS INC

Offering
$18.3M
Sold
$18.3M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
WALTHAM, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (16)

Reinhard J. Ambros · Waltham, MADirectorJosef H. Von Rickenbach · Lexington, MADirectorAlan H. Musso · Waltham, MADirectorNolan H. Sigal, M.D., Ph.D · Waltham, MADirectorWilliam H. Fairey · Waltham, MADirectorManuel Alves-Aivado, M.D., Ph.D · Waltham, MAExec · DirectorBrian L. Windsor, Ph.D · Waltham, MAExecSusan L. Drexler · Waltham, MAExecAlan H. Musso · Waltham, MADirectorReinhard J. Ambros · San Diego, CADirectorNolan H. Sigal, M.D., Ph.D · Waltham, MADirectorWilliam H. Fairey · Waltham, MADirectorJosef H. Von Rickenbach · Lexington, MADirectorManuel Alves-Aivado, M.D., Ph.D · Waltham, MAExec · DirectorBrian L. Windsor, Ph.D · Waltham, MAExecSusan L. Drexler · Waltham, MAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗